You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Alafair Biosciences develops cross-linked polysaccharide hydrogel films to addres
SBC: ALAFAIR BIOSCIENCES, INC. Topic: NIGMSDESCRIPTION (provided by applicant): The goal of this STTR project is to develop a pre-formed, naturally-based hydrogel postoperative adhesion barrier with improved handling characteristics, laparoscopic deliverability, and consistent efficacy. Our technology is based on a novel, patented process that imparts exceptional elasticity and toughness on normally brittle, weak materials. Postoperative a ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
IYG-Family: Beyond the talk to effective pregnancy, STI, and HIV prevention
SBC: Radiant Creative Group, LLC Topic: NICHDDESCRIPTION (provided by applicant): The goal of this 3 year Fast-Track STTR is to develop and evaluate a home-based intervention ('it's Your Game- Family') to provide age-appropriate sexual health life skills education and training for children (11-14 years) and to enhance parents' skills and self-confidence in support of this training. IYG-Family (IYG-F) will be an on-line g ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of flow and vascular quantification software for the assessment of MR
SBC: Magnetic Resonance Innovations, Inc. Topic: NHLBIDESCRIPTION (provided by applicant): There has been a huge increase in demand for comprehensive quantitative analysis of neurovascular imaging data produced in the clinical setting for diseases such as multiple sclerosis, traumatic brain injury, stroke anddementia. Our objective in this project is to design and develop advanced image processing software that can rapidly and accurately analyze such ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
SBC: Amprion, Inc. Topic: NINDSDESCRIPTION (provided by applicant): Human prion diseases are infectious and invariably fatal forms of neurodegenerative diseases, including sporadic Creutzfeldt-Jakob disease (sCJD), the most common form, and variant CJD (vCJD) which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy. Currently there is not sensitive, objective and non-invasive biochemical di ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
The Bumps ad device for rapid non invasive quantification of touch sensation
SBC: Neuro Devices, Inc. Topic: NCATSDESCRIPTION (provided by applicant): Our proposal describes an elegant device called the Bumps that quantifies touch sensation on the fingers at low micron levels. The objectives are to diagnose peripheral neuropathy near its onset, when the possibility for reversal is highest, and to monitor either progression or reversal of neuropathy during treatment. Target neuropathies are those related to ch ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Development of a Perfusion-induced Systemic Hyperthermia Delivery Apparatus
SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC. Topic: NCIDESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer-related deaths in men and women. The prognosis for patients with advanced stage non-small cell lung cancer (NSCLC), which accounts for 75% of all new lung cancer cases, is dismal with currently available chemotherapy regimens providing only a 9-12 month median survival. Thus, our long term goal is to develop a more eff ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health